Locally Advanced Non-Small Cell Lung Cancer Clinical Trials

36 clinical trials for Locally Advanced Non-Small Cell Lung Cancer across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) — RECRUITING · PHASE2
• A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing — RECRUITING · PHASE1
• Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC — RECRUITING · PHASE2
• A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — RECRUITING · PHASE2
• Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer — RECRUITING · PHASE1
• Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC — RECRUITING · PHASE2
• Spatially fractionated induction radiotherapy to widen the therapeutic window in locally-advanced NSCLC — RECRUITING
• NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer — RECRUITING · PHASE1
• RAPART in Locally Advanced Non-small Cell Lung Cancer Patients — RECRUITING · NA
• Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer — RECRUITING · PHASE3
• Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC — RECRUITING · PHASE3
• Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT — RECRUITING · PHASE2
• Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer — RECRUITING · PHASE2
• Patient's Whole Process Follow-up Management(HOPE-1) — RECRUITING
• ERBITUX — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of DS-3939a in Participants With Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer — NOT_YET_RECRUITING · PHASE1
• Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response — NOT_YET_RECRUITING · PHASE2
• Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer — COMPLETED · PHASE1
• Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC — NOT_YET_RECRUITING · PHASE1
• Effect of Pre-operative Exercise Training on Cardiorespiratory Fitness in Patients With Locally Advanced Non-small Cell Lung Cancer Undergoing Induction Chemo-immunotherapy Followed by Surgery - a Randomized Controlled Study — NOT_YET_RECRUITING · NA
• Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC — COMPLETED · PHASE1
• Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC — NOT_YET_RECRUITING · PHASE2
• The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer — OTHER
• Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy — OTHER · NA
• Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy — OTHER · PHASE3
• Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer — WITHDRAWN · PHASE2
• A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy — OTHER · PHASE2
• Sleep Apnea and Lung Cancer — OTHER
• Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) — COMPLETED · PHASE1
• Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC — NOT_YET_RECRUITING · PHASE2
• Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone Propionate — OTHER · PHASE2
• ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial — COMPLETED · NA
• A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy — COMPLETED · PHASE2
• Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer — TERMINATED · PHASE1
• Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy — COMPLETED · PHASE2

Refine this search